Stockwinners Market Radar for October 31, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:51 EDT Calix director sells $7.28M in common stock - In a regulatory filing, Calix disclosed that its director Donald Listwin sold 100K shares of common stock on October 27 in a total transaction size of $7.28M.

18:23 EDT Brunswick CEO: We have a strong business with strong cash flow - In an interview on CNBC's Mad Money, David Foulkes said Brunswick continues to invest for the long term because the balance sheet allows it. He expects a strong Q4. The company is seeing strong demand in fiberglass brands, he noted. "We've managed the supply chain extremely well." Inventory in U.S. is down 45% from pre-Covid levels, he added.

18:03 EDT Sony says new 'Call of Duty' has biggest PS Store launch ever for franchise - Sony's (SONY) PlayStation Twitter account said that Activision Blizzard's (ATVI) "Call of Duty: Modern Warfare II" had the biggest PlayStation Store launch of all time for a "Call of Duty" game, including preorders and day one sales. The game, which is available for PlayStation 4 and PS5, is also available on PC, Xbox One (MSFT), and Xbox Series X/S. Reference Link

17:39 EDT Faraday Future names Mazars as its new independent auditor - Faraday Future "announced the appointment of Mazars USA LLP as its independent auditor. Mazars succeeds PricewaterhouseCoopers LLP, which was the Company's independent registered public accounting firm until August 23, 2022."

17:30 EDT Goodyear Tire falls 9% to $11.50 after Q3 EPS misses estimates

17:22 EDT General Electric awarded $1.09B Navy contract - General Electric was awarded a not-to-exceed $1.09B indefinite-delivery, performance-based logistics requirements contract for repair, replacement, and program support of 784 F414 engine components in support of F/A-18 aircraft. This contract includes a five-year base with no options. Work will be performed in various continental U.S. contractor locations that cannot be determined at this time and in Jacksonville, Florida. Work is expected to be completed by October 2027. Working capital funds in the amount of $81.38M will initially be issued for delivery order N00383-23-F-0DM0 as an undefinitized contract action at time of award, and funds will not expire at the end of the fiscal year. Individual delivery orders will be subsequently funded with appropriate fiscal year appropriations at the time of their issuance. One company was solicited for this non-competitive requirement pursuant to the authority set forth in 10 U.S. Code 2304, with one offer received. Naval Supply Systems Command Weapon is the contracting activity.

17:06 EDT Dollar General incoming CEO Jeff Owen to be added to board - Dollar General announced Jeff Owen will be added to its board of directors upon the effectiveness of his promotion to CEO on November 1. With Owen's appointment, Dollar General's board of directors will consist of 10 total members with extensive expertise and experience across several industries. In July, Dollar General announced Owen would succeed Todd Vasos as CEO. Vasos will serve in a senior advisory position with Dollar General from November 1 through April 1, 2023, at which time he will retire from employment with the company and is expected to continue to serve as a member of the company's board of directors.

17:05 EDT Clearwater Paper sees Q4 adjusted EBITDA $38M-$48M - Says cost inflation impacting adjusted EBITDA by $7M to $11M relative to Q3. Says major maintenance outage at Lewiston, Idaho facility impacting EBITDA by $19M to $23M. Says expects positive impact of previously announced price increases. Says lower tissue volumes due to seasonality. Comments and guidance taken from Q3 investor presentation slides.

16:59 EDT Varonis falls 14% to $22.99 after Q3 earnings miss, FY22 guidance cut

16:49 EDT TuSimple terminates CEO Xiaodi Hou and announces succession plan - TuSimple announced that the Board of Directors of the Company has terminated Xiaodi Hou, the CEO, President and CTO of the Company, and removed Hou from his position as Chairman of the Board and as a member of the Government Security Committee, effective as of October 30. The Company announced that Ersin Yumer, TuSimple's Executive Vice President of Operations, has agreed to serve as interim CEO and President of the Company during the pendency of the executive search. Brad Buss, our Lead Independent Director, will be Chairman of the Board. The Board is also actively engaged in the search to add new independent members to the Board. These actions have been taken in connection with an ongoing investigation led by the Audit Committee of the Board that led the Board to conclude that a change of CEO was necessary. The Board has engaged Russell Reynolds Associates to identify a new CEO with relevant experience.

16:46 EDT Herbalife Nutrition withdraws FY22 guidance - The company states: "Given the rapidly shifting macroeconomic sentiment and backdrop, as well as increased volatility in the marketplace, the Company is withdrawing FY 2022 guidance. The Company will periodically reassess its ability to provide guidance when we believe future performance can be reasonably estimated."

16:40 EDT Goodyear Tire expects cost inflation to peak in Q4 - The company said, "During the fourth quarter, we expect the continuation of many of the same underlying trends we saw during the third quarter. Given energy price escalation in Europe and reduced third quarter volumes, however, we now expect cost inflation to peak in the fourth quarter, rather than the third. We expect continued benefits from strong price/mix supported by previously announced price increases for consumer and commercial replacement products. Raw material costs are expected to be up by about $500 million in the fourth quarter, which includes the impact of the stronger dollar and higher transportation and supplier costs. Some raw material costs originally expected to occur in the third quarter will now be realized in the fourth quarter, given lower-than-expected third quarter volumes. Recent trends suggest an improvement in key feedstocks like carbon black, natural rubber and steel - which could benefit results in 2023 if trends continue. Based on today's spot rates, we expect year-over-year cost increases of $300 to $400 million in the first half of 2023, with most occurring in the first quarter. We expect price/mix to exceed raw material costs, with a net benefit similar to what we saw in the third quarter. We estimate the impact from calculated and excess (non-raw material) inflation in the fourth quarter to be $250 to $300 million compared with the fourth quarter of last year. We expect our book tax rate to remain elevated for the fourth quarter, although it will remain sensitive to movements in income across geographies."

16:36 EDT American Water names Mike Doran deputy COO, David Bowler as deputy CFO - American Water Works "announced that Mike Doran, currently president of Pennsylvania American Water, has been named Deputy Chief Operating Officer at American Water reporting to Executive Vice President and COO Cheryl Norton. David Bowler, currently Senior Vice President of Planning, Regulatory and Financial Services, has been named Deputy Chief Financial Officer and Treasurer, reporting to Executive Vice President and CFO John Griffith."

16:33 EDT Ryman Hospitality sees FY22 adjusted EBITDAre $538.5M - Reed concluded, "Despite the current economic uncertainty, our collection of unique hotel properties and entertainment venues continues to generate strong interest and financial results from group and leisure travelers. The visibility that the contractual nature of our core hospitality business provides is a differentiating strength that gives us the confidence and opportunity to continue to invest in new and exciting offerings for our guests. Given our strong performance in the third quarter, and our confidence in the remainder of the year, we are again raising our full year 2022 guidance to a consolidated Adjusted EBITDAre midpoint of $538.5 million, a $12.5 million increase over our previously updated guidance midpoint given in August. We believe that our business is uniquely positioned for success and look forward to continuing to execute the long-term strategy of our Company."

16:33 EDT Axonics falls 7% to $67.90 after Q3 results and guidance

16:28 EDT Tenable announces Michelle VonderHaar as chief legal officer, general counsel - Tenable (TENB) announced that it has appointed Michelle VonderHaar to chief legal officer and general counsel. VonderHaar brings 30 years of domestic and international legal experience, having held senior roles at several technology companies directing M&A, corporate financing, governance, compliance, litigation, global trade and other legal matters. VonderHaar most recently served as senior vice president, deputy general counsel and assistant secretary at HP (HP), driving the transformation of the company's commercial global legal affairs team, expanding from a three-region model to nine geographic markets.

16:28 EDT AMN Healthcare announces Cary Grace as next CEO suceeding Susan Salka - AMN Healthcar announced Cary Grace as the company's next president and chief executive officer to succeed Susan Salka, who announced her retirement earlier this year. "The AMN Board of Directors was deeply committed to selecting a proven executive who will continue AMN's exceptional growth and impact, while also honoring our incredible culture," Chairman Doug Wheat said. "Cary stands out as a leader who will build upon our operational and organizational strengths to ensure AMN's outstanding performance now and for years to come. Cary embodies AMN's team spirit, and I know she will be passionate in our purpose, our responsibilities and our opportunities as she guides this amazing company in the next phase of its evolution."

16:26 EDT Varonis announces $100M share repurchase program - Varonis announced share repurchase program authorization allowing repurchases of up to $100M expected to be completed over the next 12 months.

16:18 EDT Denbury announces CO2 transport and storage agreement - Denbury "announced that its subsidiary, Denbury Carbon Solutions, LLC. has executed a CO2 Services Agreement with Clean Hydrogen Works. Under the definitive agreement, Denbury will transport and sequester CO2 captured from Clean Hydrogen's planned hydrogen-ammonia complex in Ascension Parish, Louisiana, which is anticipated to be built less than two miles from Denbury's existing CO2 pipeline network. The planned clean hydrogen-ammonia complex, Ascension Clean Energy, is expected to include two world-scale ammonia blocks with estimated ammonia production totaling 7.2 million tons of ammonia per year. Approximately 75% of the planned ammonia production volume is supported by letters of intent offtake agreements with high-quality purchasers."

16:16 EDT IronNet announces receipt of continued listing standard from NYSE - IronNet "announced that on October 25, 2022 it received written notice from the New York Stock Exchange that the Company is not in compliance with the continued listing standards set forth in Rule 802.01C of the NYSE Listed Company Manual that requires listed companies to maintain an average closing share price of at least $1.00 over a consecutive 30 trading-day period. The NYSE rules require the Company to notify the NYSE, within 10 business days of receipt of the Notice, of its intent to cure this deficiency. The Company has six months following the receipt of the Notice to cure the deficiency and regain compliance. The Company's common stock will continue to be listed and trade on the NYSE during this period, subject to the Company's compliance with other NYSE continued listing standards."

16:13 EDT Stryker expects adverse EPS, revenue impact from foreign exchange rates - The company said, "Considering our third quarter results, the strong order book for capital equipment and the sales momentum in our implant and capital businesses, we now expect full year 2022 organic net sales growth(2) to be in the range of 8.5% to 9.0%. If foreign currency exchange rates hold near current levels, we now expect net sales in the full year to be adversely impacted by approximately 4% and adjusted net earnings per diluted share(2) to be adversely impacted by approximately $0.35 to $0.40 in the full year. Based on our performance in the third quarter including consideration of continued inflationary pressures, together with our strong sales and additional cost reduction actions, and most significantly, the anticipated future impact of foreign currency, we now expect adjusted net earnings per diluted share(2) in the range of $9.15 to $9.25 per share."

16:11 EDT Credit Acceptance says Ravi Mohan joins as CTO - Credit Acceptance Corporation announced that Ravi Mohan joined our senior leadership team as Chief Technology Officer on October 24, 2022. In his role, Ravi will be responsible for the technologies that support our team members, dealers, and consumers-driving the successful implementation of technologies that grow the business, as well as providing services and products that help us meet our strategic Company goals. Ravi most recently served as Senior Vice President of Engineering and CIO at Datto, . At Datto, Ravi was responsible for leading all Digital Experience, Technology and Integration platfrms and driving the enterprise-wide priority and roadmap. He also led internal IT and all employee experience platforms and tools.

16:10 EDT Red Robin announces retirement of CFO Lynn Schweinfurth - Red Robin Gourmet Burgers announced a series of permanent and interim executive appointments as part of the formation of a new leadership team that will support President and Chief Executive Officer G.J. Hart in driving growth and long-term shareholder value. With the retirement of Lynn Schweinfurth, the executive leadership team will now include Todd Wilson, Chief Financial Officer, who will be joining the Company on Nov 7th. In addition, Sarah Mussetter will be rejoining the company on December 5th as Chief Legal Officer, while Jeff Hoban will continue to serve as Interim Chief Legal Officer until Ms. Mussetter's arrival. Deena DePhillips, VP Technology, will lead the IT organization and Amy Woolen, VP Marketing & Brand Management, will lead Marketing until a new CIO and CMO are appointed. Both will report to G.J. Hart in the interim. G.J. Hart, Red Robin's President and Chief Executive Officer said, "I am thrilled to announce new additions to the executive leadership team. Since becoming CEO in early September, my focus has been to build upon the foundation that has been laid so we can best fulfill our brand promise and deliver a differentiated restaurant experience to our guests. I believe both Todd and Sarah bring abundant experience and expertise to help us achieve these objectives. I also want to extend my gratitude to Jeff, Deena, and Amy for demonstrating their dedication to Red Robin and for serving in interim capacities. They bring a plethora of talent to fulfill the duties of these roles."

16:03 EDT Bombardier to quarduple current maintenance footprint in Florida - Bombardier announced the official inauguration of its new Miami-Opa Locka Service Centre at the Miami-Opa Locka Executive Airport, or OPF, in Miami-Dade County, Florida. The new facility is a testament to Bombardier's commitment to the U.S. and nearby Latin American markets and it establishes a key building block in its growing global customer support network. At full capacity, the new OEM-operated Miami-Opa Locka Service Centre plans to add close to 300 aerospace jobs in the community, including more than 225 highly skilled technicians. Once fully ramped up, the 300,000 square foot facility will more than quadruple Bombardier's current maintenance footprint in Florida and allow the company to transfer its service center operations from Fort Lauderdale to the new customer service center at Miami-Opa Locka Executive Airport, located close to Miami's business district.

15:30 EDT Canon U.S.A. announces sales and distribution partnership with DigiTech - Canon U.S.A. announced a new sales and distribution partnership with DigiTech, a graphics equipment manufacturer, based in San Antonio Texas, with servicing capabilities for numerous industries from small businesses to Fortune 500 companies. Shinichi "Sam" Yoshida, executive vice president and general manager of Canon U.S.A., said: "With our expertise in the wide-format flatbed product space, and DigiTech's industry knowledge and support capabilities, we believe this working relationship will provide both customer bases with continuously evolving solutions to meet new and existing challenges in the print space."

14:55 EDT ViaSat granted milestone extension for VIASAT-3 satellite - ViaSat was granted a milestone extension for the VIASAT-3 satellite, the FCC announced. Reference Link

13:03 EDT Deere enters partnership as investor in Advantage Capital's EPC growth fund - Deere & Company announced it will be entering a partnership as a limited investor in Advantage Capital's Empower the Change growth fund, which provides entrepreneurs of color access to capital in order to grow their businesses and create community wealth. Deere's commitment to the fund as a lead investor is part of the company's broader objective of allocating $500M within the next three years to identify and grow relationships with underrepresented and disadvantaged business enterprises, creating a more diverse and sustainable supplier network within the agriculture industry. "John Deere is committed to strengthening underrepresented communities and creating equitable wealth within the agriculture industry," said Wallas Wiggins, vice president of global supply management and logistics for Deere. "This announcement supports our company's history of advocating for-and investing in-opportunities that advance social and economic change. We look forward to seeing the positive impact within the lives and livelihoods of the small suppliers the Empower the Change fund will help scale."

12:51 EDT Xcel Energy proposes to exit coal by 2030 - Xcel Energy announced a proposal to advance the retirement of coal operations at Tolk Generating Station in Texas to 2028, more than four years earlier than planned. "With this earlier retirement, along with accelerated coal plant retirements in other states, the company will exit the use of coal by the end of 2030 when the Comanche 3 coal unit in Colorado retires," the company stated. In November, Xcel Energy will propose to New Mexico regulators to move Tolk's retirement date, previously set in the 2032-34 timeframe, to 2028. The proposal will go before Texas regulators in February 2023. Xcel Energy plans to continue operations of currently installed synchronous condensers at Tolk after 2028 as they continue to help ensure the stability of the regional grid. "As the first energy provider in the nation to set ambitious goals for addressing all the ways our customers use energy - electricity, heating and transportation - we are always striving to provide our customers cleaner energy resources, while saving them money. Advancing the retirement of coal operations at Tolk Station demonstrates our commitment to our clean energy strategy, while ensuring our customers and communities have reliable, affordable and safe service," said Bob Frenzel, chairman, president and CEO of Xcel Energy.

12:03 EDT Electronic Arts, Marvel Entertainment enter multi-title collaboration - Electronic Arts Inc. (EA) announced it is collaborating with Marvel (DIS) on a long-term deal to develop at least three new action adventure games that will be available for consoles and PC. Each of these games will be their own original story set in the Marvel universe with the first title in-development being a single player, third person, action-adventure Iron Man game coming out of Motive Studios.

12:01 EDT ProShares UltraShort Bloomberg Natural Gas falls -11.6% - ProShares UltraShort Bloomberg Natural Gas is down -11.6%, or -$2.67 to $20.26.

12:00 EDT Membership Collective rises 13.2% - Membership Collective is up 13.2%, or 58c to $4.96.

12:00 EDT Getty Images rises 36.6% - Getty Images is up 36.6%, or $1.85 to $6.90.

11:42 EDT Dragonfly Energy Holdings Corp trading resumes

11:07 EDT Peapack-Gladstone appoints Frank Cavallaro as Senior EVP, CFO - Peapack-Gladstone announced that Frank Cavallaro will join the Company and the Bank as Senior Executive Vice President, effective October 31, 2022, and will assume the role of CFO on November 10, 2022. Cavallaro joins the Bank from Republic Bank, where since 2012, he was Executive Vice President and CFO. Cavallaro will replace Jeffrey Carfora, who last month announced his intention to retire on April 7, 2023. Upon Mr. Cavallaro assuming the role as CFO, Mr. Carfora will step down, but will remain with the Company as a senior officer until April 7, 2023, to assist with transitional matters.

11:04 EDT Instagram confirms ongoing outage - In a tweet, Instagram Communications said, "We're aware that some of you are having issues accessing your Instagram account. We're looking into it and apologize for the inconvenience. #instagramdown" Reference Link

10:47 EDT EXFO receives C$15.9M contribution from Canadian government - EXFO shared the benefits to be derived from C$15.9M in funding from the federal government, including accelerating 5G technology development and job creation. The contribution will enable EXFO to establish a 5G Centre of Excellence in Montreal and create 50 high-skills job opportunities, primarily to be located in Montreal. The infusion of funding for EXFO under the Ministry of Innovation, Science and Economic Development's Strategic Innovation Fund was announced at EXFO's Montreal office by Rachel Bendayan, Parliamentary Secretary to the Minister of Tourism and Associate Minister of Finance.

10:02 EDT BCB Bank selects Q2 Holdings' digital banking platform - Q2 Holdings, Inc. (QTWO) announced that New Jersey-based BCB Bancorp (BCBP) has selected Q2's digital banking platform to deliver a seamless, modernized digital experience to its commercial and consumer banking customers. With more than $3.26 billion in assets and 28 branches throughout New Jersey and New York, BCB will deploy Q2's seamless user experience to better serve both its commercial and consumer customers.

10:00 EDT DoorDash falls -8.6% - DoorDash is down -8.6%, or -$4.03 to $43.03.

10:00 EDT Terran Orbital rises 23.8% - Terran Orbital is up 23.8%, or 61c to $3.17.

10:00 EDT Perfumania rises 29.6% - Perfumania is up 29.6%, or $4.68 to $20.48.

09:57 EDT Hoth Therapeutics Inc trading halted, volatility trading pause

09:49 EDT AMTD Digital Inc - ADR trading halted, volatility trading pause

09:47 EDT Petrobras falls -6.3% - Petrobras is down -6.3%, or -84c to $12.61.

09:47 EDT GameStop rises 11.8% - GameStop is up 11.8%, or $3.33 to $31.50.

09:47 EDT Terran Orbital rises 28.1% - Terran Orbital is up 28.1%, or 72c to $3.28.

09:40 EDT GameStop trading resumes

09:37 EDT Getty Images trading resumes

09:34 EDT Harbor Custom Development signs LOI to acquire Washington land for $4.6M - Harbor Custom Development announced it has executed a letter of intent for the acquisition of 15 acres in Stanwood, Washington for $4,590,000. Located 53 miles north of Seattle in Snohomish County, the Stanwood site is ideally suited for garden-style apartments. The property is conveniently located with easy access to the I-5 corridor, retail services, and approximately 20 minutes from the Cascade Industrial Center, a 4,000-acre manufacturing and industrial zone that is anticipated to add an additional 20,000 family-wage jobs over the next decade. Commencement of construction on the multi-family project is estimated to begin in the first quarter of 2024 following the completion of entitlements.

09:32 EDT Osino Resources receives 20-year mining license for Twin Hills - Osino Resources is pleased to report on significant progress achieved to-date on the permitting process for its wholly owned Twin Hills Gold Project in Namibia. Osino recently released a pre-feasibility study for Twin Hills based on 2.15 Moz in reserves, outlining a 13-year open-pit mine life with an average annual gold production rate of 169koz per annum at all-in sustaining costs of US$930/oz in the 10 years of operation. The granting of the mining license confirms Twin Hills' position as a rapidly advancing, partially permitted, top-tier project in a premier jurisdiction. Heye Daun, Osino's co-founder, President & CEO commented: "We are very pleased to have received confirmation from Namibia's Ministry of Mines and Energy for the Preparedness to Grant of a 20-year mining license for the Twin Hills Gold Project subject to the fulfilment of some remaining conditions which are customary under Namibia's regulatory regime. Receipt of the mining license is a major endorsement of the progress Osino has made with the advancement of the Twin Hills Gold Project and confirms the support of the Namibian government for the ongoing development of the project. Twin Hills's stature as one of Namibia's most exciting mining development projects continues to grow and we are very appreciative of the partnership shown by all Namibian permitting authorities throughout this process." The Namibian Ministry of Mines and Energy has now completed their review of the Mining License application, which was submitted in August 2021, and subsequently issued a Mining License for Twin Hills subject to certain customary conditions. These conditions include fulfilling an employment quota for certain disadvantaged Namibian groups, making available a 5% carried interest by certain disadvantaged Namibian groups, issuance of the Environmental Clearance Certificate by the Namibian Ministry of Environment, Fisheries and Tourism, and obtaining the remaining secondary permits to operate the mine. In conjunction with the Mining License application process, an Environmental and Social Impact Assessment was completed. The ESIA included full baseline specialist studies and extensive stakeholder engagement which took place during most of 2021 and early in 2022. The completed ESIA and Environmental Management Plan were submitted to the MEFT in March 2022, who reviewed the full impact assessment documentation and have found no fatal flaws. The review and issuance of the ECC is in its final stages. One of the outstanding aspects is the conclusion of an appropriate engagement, documentation, and management process for the relocation of historic graves at the Twin Hills project site. Stakeholders have agreed to the relocation of the graves to a new site to be agreed upon. Osino is currently preparing to submit a final report to Namibia's National Heritage Council including recently completed stakeholder engagements and mitigation measures. Following this, the NHC is expected to submit its recommendation to the MEFT with respect to the issuance of the ECC for the Twin Hills project.

09:21 EDT eBay completes acquisition of TCGplayer - eBay announced it has completed its acquisition of TCGplayer, a marketplace for collectible card game enthusiasts, for a total deal value of up to approximately $295M. TCGplayer will continue to operate autonomously as one of the largest online marketplaces for trading card games.

09:18 EDT Pzena Investment completes transaction to become private - Pzena Investment Management announced the completion of its previously announced take-private transaction. Effective today, PZN will operate as a privately-held company owned by the existing partners of Pzena Investment Management, LLC. PZN stockholders approved the transaction at a special meeting on October 27, 2022. As a result of the completion of the transaction, PZN Class A stockholders will receive $9.60 per share in cash for each Class A share owned immediately before the closing of the transaction. PZN stock ceased trading [prior to market open today] and will no longer be listed on the New York Stock Exchange.

09:11 EDT Limoneira closes sale of Oxnard Lemon Packing Facility - Limoneira announced it has closed its previously announced sale of its Oxnard Lemon Packing Facility in Ventura County, California to Ventura County Railway Company for $20M in cash proceeds. The company expects to record an approximate gain of $900,000 on this transaction to be recognized in the fiscal fourth quarter ending October 31 and utilize the $20M proceeds to reduce the company's debt.

09:10 EDT Sema4 Holdings supports new guidelines recommending exome sequencing - Sema4 supports the new National Society of Genetic Counselors guidelines recommending exome sequencing as a first-tier test, to be prioritized over multi-gene panels for all individuals with unexplained epilepsy. This is the first evidence-based guideline for genetic testing for individuals with unexplained epilepsy, and the implications are vast, as a significant amount of unexplained epilepsy has a genetic cause. These recommendations mirror guidelines for other neurodevelopmental disorders such as intellectual disabilities and developmental delays in that they recommend genome and exome sequencing as first-tier tests.

09:07 EDT Rambus and Samsung extend comprehensive pact for additional 10 years - Rambus (RMBS), nnounced it has extended its comprehensive patent license agreement with Samsung Electronics (SSNLF), for an additional ten years. The extension substantially maintains the existing financial terms and provides Samsung with broad access to the full Rambus patent portfolio through late 2033. Other terms and details are confidential. "Samsung has been a trusted partner for many years, and we are very pleased to extend our strategic relationship," said Luc Seraphin, president and chief executive officer of Rambus. "This extension enables deeper collaboration to deliver even greater value to the industry, and we are excited to continue working with such an innovative industry leader."

09:06 EDT Digital Ally announces next generation fleet video solution - Digital Ally announced its "most advanced video system to date for fleet vehicles," the company said. The full-featured solution utilizes the latest in telematics technology, including immediate driver-assist feedback by recognizing pedestrians, distracted or drowsy driving, and lane shifting.The Digital Ally sales team will unveil the EVO Fleet at booth #205 of The Transportation Alliance Mobilize 2022 104th Annual Convention & Expo being held Caesars Palace in Las Vegas, NV October 30 - November 2, 2022. "We're proud of our newest fleet video system and what it will do to help fleet organizations optimize safety and security for their drivers and other critical assets," said Stan Ross, CEO of Digital Ally, adding, "Our partners in insurance, outfitting, and more - both domestic and international - are equally as excited as we are to begin marketing and deploying this new technology."

09:04 EDT iClick Interactive Asia implements ADS ratio change - iClick Interactive Asia will change the ratio of the American depositary shares representing its Class A ordinary shares from one ADS representing one-half of one Class A ordinary share to one ADS representing five Class A ordinary shares. For the ADS holders, the change in the ADS ratio will have the same effect as a one-for-ten reverse ADS split. There will be no change to the company's Class A ordinary shares. The effect of the ratio change on the ADS trading price on Nasdaq is expected to take place at the open of trading on November 14. ADS holders of record on the effective date will not be required to take any action in connection with the ADS ratio change. The ADSs will continue to be traded on Nasdaq under the symbol "ICLK." No fractional new ADSs will be issued in connection with the change in the ADS ratio. As a result of the change in the ADS ratio, the ADS price is expected to increase proportionally.

09:02 EDT Arthur J. Gallagher acquires f3 Companies - Arthur J. Gallagher acquired the f3 Companies. Terms of the transaction were not disclosed. Included in the acquisition are Burnsville, Minnesota-based f3Logic; Burnsville, Minnesota-based f3Investment Management; Richmond, Virginia-based Financial Consultants of America; Wakefield, Massachusetts-based Compass Point Retirement Planning; and Burnsville, Minnesota-based Kusske Financial Asset Management. The f3 Companies are a wealth management platform with over $1B in assets under advisement. With a turnkey technology and asset management platform and an investment suite of offerings, the f3 Companies provide retirement planning and financial advisory services to individuals, individual advisors and registered investment advisory firms. The f3 Companies will remain in their current locations under the direction of Jeff Leonard, Gallagher's North American Business Line Leader for Financial and Retirement Services.

08:59 EDT Biofrontera enters into agreements to purchase options of Biofrontera AG - Biofrontera announced it has entered into private exchange agreements with certain holders of options to acquire ordinary shares of Biofrontera AG in exchange for 3,148,042 newly issued shares of Biofrontera common stock. The AG Options represent the right to acquire 2,623,365 ordinary shares of Biofrontera AG held by the shareholders, or approximately 4.63% of Biofrontera AG's outstanding ordinary shares. "This transaction represents a major milestone in the strategic positioning of Biofrontera Inc. We strive to distinguish ourselves as an independent U.S. based biopharmaceutical company, exclusively serving the world's largest dermatology market," stated Erica Monaco, Chief Executive Officer of Biofrontera Inc. "The agreements will further strengthen our position and realize our full commercial potential in this fast-growing market. At the same time, the transaction underscores the strength of our relationship with our former parent company Biofrontera AG. As the key driver of Biofrontera AG's products' sales growth and their largest source of revenue, we will continue to work together closely," she added. "This will enable us to support our mutually beneficial interests, especially in the areas of intellectual property, manufacturing, regulatory affairs and clinical trials."

08:58 EDT Align Technology CEO Joe Hogan to purchase additional $2M of common stock - Align Technology announced that it has entered into a new accelerated stock repurchase agreement, or ASR, with Goldman Sachs & Co., to repurchase $200M of Align's common stock under Align's $1B stock repurchase program announced on May 13, 2021. In addition to the ASR, Joe Hogan, president and CEO, intends to personally purchase $2M of Align's common stock, in addition to his $2.0M purchase in May 2022.

08:52 EDT Grid Dynamics achieves The AWS Service Delivery Designation for Amazon EKS - Grid Dynamics Holdings announced that it has achieved the Amazon Web Service AWS Service Delivery designation for Amazon Elastic Kubernetes Service Amazon EKS as an inaugural recipient. Grid Dynamics received the AWS Service Delivery designation for Amazon EKS for its proven success in helping customers architect, deploy, and operate containerized workloads on top of Amazon EKS.To receive this designation, AWS Partner Network members must possess deep AWS experience and deliver solutions seamlessly on AWS. This designation differentiates Grid Dynamics as a company that can help customers manage, deliver, and optimize containerized workloads with Amazon EKS."The recognition from AWS establishes Grid Dynamics as an inaugural recipient for AWS Service Delivery on Amazon EKS and the next wave of cloud modernization," said Chuck Tsocanos, Vice President, Modern Application Development for Grid Dynamics. "Companies are beginning to capture true value from the cloud by leveraging it as a development and data platform rather than a data center alternative. Given our work with AWS, our customers can rely on us to remove the complexity of building and managing cloud services and applications. In addition, they can turn to Grid Dynamics to help accelerate the time to market for those services."

08:44 EDT Duck Creek Technologies announces automated test integration with SPLICE - Duck Creek Technologies announces that Mutual Benefit Group has selected its out-of-the-box automated text integration with SPLICE Software embedded into the Duck Creek platform. Utilizing this technology directly within Duck Creek Claims, insurers can now better lead strategic communication programs, ensuring that customers are engaged and at ease. "We are proud that Duck Creek's partner ecosystem can enable Mutual Benefit Group to increase its customer engagement throughout the entire claims lifecycle," said Robert Fletcher, Senior Partner Manager, Duck Creek Technologies. "At a time when people are eager to explore new channels of communication, our customers can have a more humanized experience that is convenient, engaging, and secure. We are keen on working with ecosystem partners like SPLICE that set the bar high and take the user experience to the next level."

08:42 EDT Align Technology announces $200M accelerated share repurchase agreement - In a regulatory filing, Align Technology (ALGN) announced it entered into an accelerated share repurchase agreement with Goldman Sachs & Co. (GS) to repurchase $200M of Align's common stock authorized under the company's $1B stock repurchase program announced on May 13, 2021. Under the ASR contract, Align will make an initial payment of $200M to Goldman and will receive an initial delivery of approximately 849,000 shares of common stock.

08:40 EDT ReShape Lifesciences announces ASMBS, IFSO updated guidelines - ReShape Lifesciences announced that the American Society for Metabolic and Bariatric Surgery, ASMBS, and the International Federation for the Surgery of Obesity and Metabolic Disorders, IFSO, have issued updated guidelines for Metabolic and Bariatric Surgery, including the Lap-Band, replacing the 30 year old guidelines issued by the National Institutes of Health, NIH, in 1991. The ASMBS/IFSO Guidelines now recommend metabolic and bariatric surgery for individuals with a BMI of 35 or more, regardless of the presence, absence or severity of obesity-related conditions, and that it be considered for adults with a BMI 30-34.9 and metabolic disease, and in appropriately selected children and adolescents. "The compelling evidence-based standards issued by the ASMBS and IFSO, if supported by payers, can dramatically increase the number of patients eligible for bariatric surgery and it is our strong belief that among the approved procedures, the personalized Lap-Band will prevail as the least invasive surgical treatment option to help address the global obesity epidemic," stated Paul Hickey, President and Chief Executive Officer of ReShape Lifesciences. "We applaud the leadership of these two industry-leading societies, working together to update these guidelines for bariatric surgery. These new guidelines align well the Lap-Band, which is approved by the U.S Food and Drug Administration for adult patients with a BMI over 30, with at least one obesity-related comorbidity as well as any patient with a BMI over 40. Importantly, the Lap-Band, backed by 25 years of clinical evidence, is the only FDA approved laparoscopic weight loss device on the market. We are optimistic that these new guidelines will improve access to care for people who seek a safe and effective treatment for durable weight loss, improvement in obesity related comorbidities and quality of life."

08:38 EDT Farmer Bros. announces board refresh, cooperation agreement - Farmer Bros announced it has entered into a cooperation agreement with JCP Investment Management and 22NW, which together own approximately 15.7% of the Company's outstanding common stock. Under the Cooperation Agreement, the Company has agreed to promptly appoint Bradley Radoff as an independent member of the Board of Directors. The Company will also include Radoff and an additional independent nominee from JCP's nomination notice on its slate of candidates standing for election at the 2022 Annual Meeting of Stockholders. Upon election to the Board, the Second New Director will fill a vacancy created by the retirement of Charles Marcy from the Board at the 2022 Annual Meeting. Following the 2022 Annual Meeting, Christopher Mottern will retire from the Board, effective as of June 30, 2023. The size of the Board will not exceed eight after Mr. Mottern's retirement. The Company also agreed to form a new committee of the Board tasked with reviewing strategic alternatives and capital allocation initiatives promptly following the 2022 Annual Meeting. Additionally, JCP has agreed to withdraw its notice of intent to nominate director candidates for election at the 2022 Annual Meeting and both JCP and 22NW have agreed to cease all solicitation and other activities in connection with the 2022 Annual Meeting.

08:37 EDT Camber Energy's subsidiary announces notice of allowance for patent - Camber Energy announced that Viking's majority-owned subsidiary, Viking Ozone Technology received a Notice of Allowance from the United States Patent & Trademark Office for patent application No. 17/576,801 titled "Multi-Chamber Medical Waste Ozone-Based Treatment Systems and Methods". A Notice of Allowance is issued after the USPTO makes the determination that a patent should be granted from an application. A patent from the recently allowed application is expected to be issued in the coming months.

08:35 EDT Verisk Analytics to sell Wood Mackenzie to Veritas Capital for $3.1B - Verisk and Veritas Capital announced the signing of a definitive agreement under which an affiliate of Veritas has agreed to acquire Verisk's Energy business, Wood Mackenzie, for $3.1 billion in cash consideration payable at closing plus future additional contingent consideration of up to $200 million. Wood Mackenzie is a globally recognized industry leader that has been providing quality data, analytics, and insights used to power the energy, renewables, and natural resources industry for nearly 50 years. The Wood Mackenzie Lens platform enables world class analytics and insights to drive critical decision making for the company's longstanding clients that operate at the leading edge of the rapidly evolving energy sector. Since joining Verisk in 2015, Wood Mackenzie has developed strong data and analytics capabilities and is now advantageously positioned at the nexus of energy industry tailwinds, offering clients leading renewable energy and energy transition data and analytics with the bold purpose of transforming the way the planet is powered. The total purchase price is subject to typical adjustments for, among other things, the working capital and the debt of the business at closing. Verisk intends to use the after-tax proceeds to pay down debt and return value to shareholders through share repurchases. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2023.

08:32 EDT SHF Holdings to acquire Abaca for $30M - SHF Holdings has entered into an agreement to acquire Rockview Digital Solutions, Inc d/b/a Abaca, a cannabis financial technology platform that has processed more than $3B in gross transactions, for $30M. Built on modern cloud-hosted technology by banking and compliance experts, Abaca's digital-first commercial banking solutions make cannabis banking easy by revolutionizing access to cutting-edge banking and financial solutions. The transaction is structured to provide Abaca shareholders with $3M cash at close and $8.4M in common stock based on the 10-day VWAP of Safe Harbor common stock. At the 1-year anniversary, the company will pay an additional $3M in cash and $12.6M in Safe Harbor common stock based on the 10-day VWAP preceding the 1-year anniversary. Upon the 2-year anniversary, there will be a final cash payment of $3M in cash. The transaction is expected to close this quarter, subject to regulatory approvals and other customary closing conditions.

08:30 EDT Maquia Capital Acquisition says advancing toward agreement to close combination - Maquia Capital Acquisition Corporation announced that it is working diligently with a target company toward a definitive agreement. The Company considers the Target to be a potentially high-growth company in the fintech sector. The Company expects to announce additional details regarding the currently proposed business combination over the next months in the event of the execution of any definitive agreement. No assurances can be made that the parties will successfully negotiate and enter into a definitive agreement, or that the proposed transaction will be consummated on the terms or timeframe currently contemplated, or at all. Any transaction would be subject to board and stockholder approval of both companies, regulatory approvals and other customary conditions.

08:28 EDT Ortho Dermatologics announces U.S. launch of Podiatry Board Review Challenge - Bausch Health Companies business, Ortho Dermatologics, recently announced the launch of the Podiatry Board Review Challenge, a new professional educational resource. Developed alongside practicing podiatrists, the Podiatry Board Review Challenge is designed to help support residents preparing for their board certification exams, podiatric healthcare professionals preparing for re-certifications and podiatrists who are looking to refresh their skills and knowledge.

08:27 EDT Lifeist's CannMart enters distribution agreement with Hamilton Devices - Lifeist Wellness announced that its wholly owned Canadian cannabis business unit, CannMart, has entered into a distribution agreement with Hamilton Devices. With the agreement, CannMart is now Canada's first distributor of Hamilton Devices' complete portfolio of innovative consumer facing, extracts focused vape hardware products across Canada through October 2024, with an initial six-month exclusivity. "We're excited to bring new products to market that complement CannMart's Roilty product line," said Meni Morim, CEO of Lifeist. "Providing consumers with new, safe and convenient ways to try and consume our extract products will not only delight our customers but can also help us grow our core cannabis business faster and more efficiently. The Hamilton Devices product line fits perfectly into CannMart's existing portfolio and sales process, and we are looking forward to seeing the results of this new agreement."

08:26 EDT Capstone Green Energy secures Energy-as-a-Service rental contracts - Capstone Green Energy has secured several new Energy-as-a-Service, or EaaS, rental contracts, pushing its total of rented or under contract to 39 MW. The company expects it will reach its 50 MW target by March 31, 2023. These new contracts represent the continued expansion of the EaaS strategy and is indicative of ongoing customer demand. These most recent wins demonstrate the company is on track with its vision to create economically attractive, smarter energy solutions and builds on its track record of enabling its customers to save $911M in energy costs and approximately 1,503,100 tons of carbon emissions over the last four years.

08:25 EDT SLB and Linde collaborate on carbon capture and sequestration - SLB ( SLB) and Linde (LIN) announced that they have entered into a strategic collaboration on carbon capture, utilization and sequestration CCUS projects to accelerate decarbonization solutions across industrial and energy sectors. The collaboration will combine decades of experience in carbon dioxide capture and sequestration; innovative technology portfolios; project development and execution expertise; and engineering, procurement, and construction capabilities. CO2 is found or produced in many industrial and energy applications. This collaboration will focus on hydrogen and ammonia production, where CO2 is a by-product, and in natural gas processing. CCUS abates the emissions from these energy-intensive industries, creating new low-carbon energy sources and products. The International Energy Agency estimates1 that over 6Gt of CO2 per year will need to be abated with CCUS in order to reach net zero by 2050. "CCUS is vital in creating the decarbonized energy systems our planet needs to balance energy demand with climate objectives," said Olivier Le Peuch, chief executive officer, SLB. "We are excited about this collaboration with Linde to develop CCUS projects and support the growth of low-carbon energy products from conventional energy sources."

08:24 EDT Victoria Gold files technical report on Raven Gold Deposit - Victoria Gold announces that it has filed a technical report prepared in accordance with 43-101 - Standards of Disclosure for Mineral Projects on the Raven Gold Deposit, located approximately 15 kilometers east of the Eagle Gold Mine. The October 26, 2022 technical report is titled "Technical Report on the Raven Mineral Deposit, Mayo Mining District Yukon Territory, Canada." The Initial MRE comprises a total Inferred Mineral Resource of 1,070,239 ounces of gold for the near-surface Raven Deposit.

08:23 EDT PropTech Investment Corporation II files proxy statement for Appreciate merger - PropTech Investment Corporation II announced that on October 28, 2022, it filed a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with PTIC's Special Meeting of Stockholders to, among other things, approve the previously announced proposed business combination with RW National Holdings, the parent holding company of Renters Warehouse, a leading end-to-end Single Family Rental marketplace and management platform.

08:20 EDT Walmart, Popable enter strategic partnership - Popable, a pop-up shop marketplace platform connecting brands and spaces for short-term retail leasing, and Walmart announced that they have entered a strategic partnership that will allow small businesses to rent retail space in Walmart stores across the country for short-term leasing. Small businesses will have the opportunity to rent out pop-up space in designated Walmart stores without being committed to a long-term lease. Brands and spaces can both list on Popable's online website (https://Popable.com). Small businesses can then be paired with their local participating Walmart to connect and enter into an agreeable temporary leasing agreement. The timeframe of these leasing agreements will be predetermined by the small business and can range in time from a month up to a year but could grow to a longer-term agreement. The terms are decided and negotiated by the brands and spaces directly themselves

08:18 EDT Enphase Energy expands IQ8 microinverter deployments in Nevada - Enphase Energy announced that installers of Enphase products in Nevada have seen growing deployments of Enphase Energy Systems powered by IQ8 Microinverters following the product's launch in North America late last year. Enphase's revolutionary IQ8-based systems can provide Sunlight Backup functionality during an outage, even without a battery. "The solar industry in Nevada is growing rapidly, providing thousands of exciting opportunities and jobs for people in the region," said Dave Ranhoff, chief commercial officer at Enphase Energy. "We are proud to work with installers in the state to help homeowners realize the value they can achieve from solar and home energy management solutions, including the economic benefits and ability to control their energy future."

08:16 EDT Yoshitsu announces new revolving credit facility - Yoshitsu announced that on September 27, 2022, the Company entered into a JPY8.15 billion revolving credit facility agreement with a syndicate of Japanese banks to support the Company's growth initiatives. The Credit Agreement lending syndicate is led by MUFG Bank, Ltd. and MUZUHO Bank Ltd. and includes 17 bank participants. Each draw advanced under the Credit Agreement will bear interest at the then Tokyo Interbank Offered Rate, or TIBOR plus 0.7 percent per annum. The obligations of the Company under the Credit Agreement are secured by the accounts receivable of the Company and are guaranteed by Mr. Mei Kanayama, the Principal Executive Officer of the Company. The Credit Agreement will expire on September 29, 2023, unless terminated earlier.

08:14 EDT Clene announces $10.8M registered direct offering - Clene announced that it has entered into a securities purchase agreement with certain existing stockholders, including existing stockholders affiliated with Clene's board of directors, for the purchase and sale of 10,723,926 shares of the Company's common stock at a purchase price per share of $1.01, priced at-the-market based on the October 28, 2022 closing stock price, in a registered direct offering. The closing of the registered direct offering is expected to occur on or about November 2, 2022, subject to the satisfaction of customary closing conditions. The gross proceeds from the offering are expected to be approximately $10.8 million. The registered direct offering is being made without a placement agent, underwriter, broker or dealer and, as a result, Clene is not paying any underwriter commission or discount. Clene intends to use the proceeds from this offering together with its existing cash for expenses primarily related to general corporate purposes, including to fund the clinical development of its lead drug candidate, CNM-Au8. The shares were offered pursuant to an effective shelf registration statement on Form S-3 previously filed with the U.S. Securities and Exchange Commission and declared effective by the SEC on April 26, 2022. Clene also announced that it has executed a Commitment Letter with the Maryland Department of Housing and Community Development to borrow $5 million. The State Small Business Credit Initiative program within DHCD was provided the source funds for the Loan Facility by the U.S. Department of Treasury. The Loan Facility is conditioned on Clene matching the $5 million loan with at least $5 million of new equity capital. The closing of the registered direct offering referenced above will satisfy that condition of the Loan Facility. Clene is targeting December 1, 2022, as the tentative closing date for the Loan Facility.

08:13 EDT SLB and Linde collaborate on carbon capture and sequestration - SLB (SLB) and Linde (LIN) announced that they have entered into a strategic collaboration on carbon capture, utilization and sequestration CCUS projects to accelerate decarbonization solutions across industrial and energy sectors. The collaboration will combine decades of experience in carbon dioxide CO2 capture and sequestration; innovative technology portfolios; project development and execution expertise; and engineering, procurement, and construction EPCcapabilities. CO2 is found or produced in many industrial and energy applications. This collaboration will focus on hydrogen and ammonia production, where CO2 is a by-product, and in natural gas processing. CCUS abates the emissions from these energy-intensive industries, creating new low-carbon energy sources and products. The International Energy Agency estimates1 that over 6Gt of CO2 per year will need to be abated with CCUS in order to reach net zero by 2050. "CCUS is vital in creating the decarbonized energy systems our planet needs to balance energy demand with climate objectives," said Olivier Le Peuch, chief executive officer, SLB. "We are excited about this collaboration with Linde to develop CCUS projects and support the growth of low-carbon energy products from conventional energy sources."

08:12 EDT Acacia Research Starboard Value announce streamlining agreement - Acacia Research and Starboard Value announced an agreement to streamline the company's capital structure, . As a result of the agreement, which provides for Starboard converting its ownership interests to common shares, Acacia has enhanced its ability to be a strategic acquirer of operating companies and positioned all of the Company's shareholders to be invested on the same terms as Starboard. The agreement provides additional capital and strengthens Starboard's strategic relationship. Gavin Molinelli, partner and portfolio manager at Starboard, will join Acacia's board of directors as chair. Clifford Press, CEO, commented, "This transaction simplifies Acacia's capital structure, bolsters access to resources to pursue acquisitions, and, most importantly, provides a fully-aligned format to leverage Starboard's strong standing in the capital markets. The transaction is specifically structured to give Acacia access to an appropriate amount of capital for our research and transaction teams to deploy. Acacia will continue to acquire attractive undervalued assets and businesses and build upon this strong partnership with Starboard."

08:11 EDT Absolute Software appoints Jim Lejeal as CFO, Samir Sherif as CISO - Absolute Software announced the appointments of Jim Lejeal as Chief Financial Officer and Samir Sherif as Chief Information Security Officer, CISO.

08:10 EDT Theriva Biologics to host KOL webinar on VCN-01 - Theriva Biologics announced that it will host a key opinion leader webinar on Monday, November 7, 2022 at 11:00 a.m. ET to discuss the oncolytic virus landscape and the encouraging data that positions the Company's novel oncolytic adenovirus platform at the forefront of development to address devastating cancers with high unmet need. The discussion will also include recent findings from independent research highlighting the market opportunities for pancreatic ductal adenocarcinoma. VCN-01, Theriva Biologic's lead clinical-stage drug candidate, is an intravenous, oncolytic adenovirus designed to break down the tumor stroma. Theriva's upcoming Phase 2 clinical trial, VIRAGE, will evaluate VCN-01 in combination with standard-of-care chemotherapy gemcitabine/nab-paclitaxel in patients with PDAC. The webinar will feature the KOLs Michael Aaron Morse, M.D., Professor of Medicine and Professor in the Department of Surgery in Medical Oncology at the Duke University School of Medicine, as well as Arsen Osipov, M.D., medical oncologist and clinical-translational investigator in the Gastrointestinal Disease Research Group and Pancreas Cancer Research Group of the Samuel Oschin Cancer Center at Cedars-Sinai. Dr. Morse is a pioneer in the use of immune therapies to treat various cancers, including gastrointestinal, breast, lung cancers and melanoma. Dr. Osipov focuses on the development of novel immunotherapy-based treatment strategies for gastrointestinal malignancies, with a focus on pancreatic cancer.

08:09 EDT Reviva Pharmaceuticals announces global enrollment uodate for RECOVER study - Reviva Pharmaceuticals Holding announced over 30% enrollment in the United States, and initiation and ongoing enrollment across sites in Europe for the pivotal Phase 3 RECOVER study evaluating brilaroxazine for the treatment of schizophrenia. The Company has received regulatory approval for initiating the study in Asia, with enrollment at multiple sites in India expected in 2022. RECOVER is a global Phase 3, randomized, double-blind, placebo-controlled, multicenter study designed to assess the safety and efficacy of brilaroxazine in approximately 400 patients with acute schizophrenia compared to placebo. Brilaroxazine will be administered at fixed doses of 15 mg or 50 mg once daily for 28 days. A 52-week open-label extension study with flexible doses of 15 mg, 30 mg, or 50 mg will further evaluate the long-term safety and tolerability of brilaroxazine in patients with stable schizophrenia. Since Reviva initiated its first clinical site at the end of January in the United States, the Company continues to make progress and is on pace with patient enrollment and site initiation in geographically diverse centers across this global clinical study.

08:08 EDT Acacia Research CEO Clifford Press to retire - Acacia Research and Starboard Value LP announced an agreement to streamline the company's capital structure, further strengthen its financial position, and position it as a unique Starboard-backed corporate acquisition platform. As a result of the agreement, which provides for Starboard converting its ownership interests to common shares, Acacia has enhanced its ability to be a strategic acquirer of operating companies and positioned all of the company's shareholders to be invested on the same terms as Starboard. Acacia also announced that CEO Clifford Press will retire from his CEO and board position, having overseen Acacia's transformation, first as a board member, then as CEO, for the last four years. MJ McNulty has been appointed as interim-CEO. McNulty has served as COO and head of M&A at Acacia since March. The board will conduct a search for a permanent successor.

08:07 EDT Crown Electrokinetics issues letter to shareholders - Crown Electrokinetics has released a letter to its shareholders. "Recently, you saw our announcement that we had begun the application process to dual list our shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited. Following the request of some of our largest shareholders, over the last few months we researched a dual listing on Upstream. Ultimately, our Board of Directors determined that a dual listing on Upstream could be an excellent way to reach a worldwide market of potential new investors who can learn about and invest in Crown... The planned dual listing on Upstream is designed to provide the Company the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and US Dollar, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in NASDAQ-listed Crown. As we recently also announced, we successfully closed on $4 million of fresh capital. This new capital will allow Crown to deliver its first-generation product, while also providing us with the runway to continue negotiating debt capital, which the Company will require to initiate our next phase of manufacturing... Our market potential continues to grow, with few, if any, comparable solutions, complemented by legislative tailwinds like the recently announced Inflation Reduction Act that expands the tax incentives for retro-fitted energy improvements and has also now made them available to the Company's REIT customers - further enhancing our already significant value proposition. Other legislation, such as New York City's Local Law 97 which targets a 40% reduction in building energy use levels by 2030, is compelling REITs to rapidly upgrade their building envelopes."

08:07 EDT Biomea Fusion doses first patient with Type 2 diabetes in COVALENT-111 trial - Biomea Fusion announced the dosing of the first patient with type 2 diabetes in the Phase II portion of COVALENT-111, a Phase I/II clinical trial underway in Canada. Biomea has completed the Phase I portion of the trial in healthy volunteers.

08:04 EDT Ardelyx partner Kyowa Kirin submits NDA for tenapanor in Japan - Ardelyx announced that its collaboration partner in Japan, Kyowa Kirin Co., has submitted a NDA to the Japanese Ministry of Health, Labour and Welfare for tenapanor for the improvement of hyperphosphatemia in adult patients with chronic kidney disease on dialysis. This submission triggers an aggregate of $35M to Ardelyx in milestone payments and payments under the recent amendment to the license agreement between Ardelyx and Kyowa Kirin. In the U.S., Ardelyx is pursuing approval of tenapanor for the treatment of hyperphosphatemia in adult patients with CKD on dialysis, with the brand name XPHOZAH, and has an appeal underway in response to the Complete Response Letter it received from the FDA for its NDA. As part of the appeal process, the FDA will convene an Advisory Committee Meeting to review XPHOZAH on November 16.

08:02 EDT Sonnet BioTherapeutics enters SON-1010 collaboration with Janssen - Sonnet BioTherapeutics (SONN) announced a collaboration agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ), where in vitro and in vivo efficacy of SON-1010, SON-1210 and SON-1410 will be evaluated in combination with certain Janssen proprietary cell therapy assets. The agreement was facilitated by Johnson & Johnson Innovation. Sonnet shall supply the three referenced compounds for use in head-to-head studies. If successful and subject to provisions of the agreement, Sonnet could seek an expanded collaboration.

07:51 EDT Small Pharma receives approval for first-in-human Phase I trial of SPL026 - Small Pharma has received approval from the U.K. Medicines and Healthcare products Regulatory Authority and the Research Ethics Committee to initiate a Phase I study of SPL028, its proprietary deuterated N, N-dimethyltryptamine candidate, with supportive therapy in healthy volunteers. Through the SPL028 program, Small Pharma is exploring a greater than30-minute short psychedelic experience aimed at optimizing patient convenience and expanding the therapeutic potential in depressive disorders and additional indications. This SPL028 Phase I study is planned to be a randomized, placebo-controlled, blinded, dose-escalating study to be conducted at MAC Clinical Research in Manchester, England. It is designed to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of intramuscular and intravenous administration of SPL028, which is expected to allow Small Pharma to better understand the profile of SPL028 as a therapeutic candidate. The study is anticipated to initiate in H1 2023.

07:41 EDT Sonnet BioTherapeutics enters agreement with Janssen for product evaluation - Sonnet BioTherapeutics (SONN) announced a collaboration agreement with Janssen Biotech (JNJ), where in vitro and in vivo efficacy of SON-1010, SON-1210 and SON-1410 will be evaluated in combination with certain Janssen proprietary cell therapy assets. The agreement was facilitated by Johnson & Johnson Innovation. Sonnet shall supply the three referenced compounds for use in head-to-head studies. If successful and subject to provisions of the agreement, Sonnet could seek an expanded collaboration.

07:38 EDT Skeena Resources announces transition of Randy Reichert to CEO - Skeena Resources announced the planned transition of Randy Reichert to the position of CEO. Mr. Reichert will now hold the position of President, CEO & Director while Walter Coles will continue to remain actively involved with the Company in his new role as Executive Chairman of the Board of Directors.

07:36 EDT CloudMD announces divestment of pharmacies to Neighbourly Pharmacy for $3.8M - CloudMD Software & Services announces that it has entered into a definitive agreement with Neighbourly Pharmacy for the sale of its British Columbia based pharmacies for approximately $3.8M. Under the Agreement, CloudMD has agreed to sell Neighbourly its two brick-and-mortar retail pharmacies, Cloverdale Pharmacy Ltd. and Steveston Health Centre, located in Surrey and Richmond BC, respectively. The divestitures of the two pharmacies will not affect the services the Company currently delivers within its core business. On October 11th, CloudMD also announced that it had entered into a definitive agreement to divest its clinics and Cloud Practice asset to WELL Health for $5.75M. In total, CloudMD has generated over $9M in non-dilutive capital as part of its strategy to divest its non-core assets and focus on the performance and growth of its core business, Enterprise Health Solutions and Digital Health Solutions. Karen Adams, CEO of CloudMD commented, "We are pleased with the progress and non-dilutive capital we've been able to generate through the divestiture of assets in our non-core Clinics and Pharmacies division. Between this transaction and the previously announced divestiture of Cloud Practice and clinics we've generated over $9 million in capital we can redeploy for the growth of our EHS Division, which will allow us to continue scaling our core business. Given these challenging and unpredictable markets, we remain focused on delivering meaningful, revenue growth, driving near-term profitability, prudent cash management and improving operating expenses to provide long-term operational consistency and stability."

07:35 EDT Saia sees 2022 net capital expenditures $500M - Saia Executive Vice President and Chief Financial Officer, Douglas Col added, "I am pleased with the year-over-year operating ratio improvement and that we were able to achieve that while still being able to provide our employees with a wage increase in July. On the cost side, we have seen a step-up in depreciation expense as new equipment has been delivered into the fleet, but we expect to see a benefit in maintenance expense and also potentially in reduced purchased transportation expense in the coming months as we run more miles with Company equipment and drivers."

07:33 EDT Marinus entered into $32.5M revenue interest financing pact with Sagard - Marinus Pharmaceuticals announced that it has entered into a revenue interest financing agreement with Sagard Healthcare Partners for a total of $32.5m upfront in return for payments based on U.S. net sales of ganaxolone, including the recently approved ZTALMY or ganaxolone, oral suspension CV. "This $32.5M of non-dilutive capital is expected to provide a meaningful extension of our cash runway into the first quarter of 2024," said Steven Pfanstiel, Chief Financial Officer of Marinus. "Importantly, this supports continued commercial and R&D investment inclusive of our current ZTALMY launch, as well as our ongoing Phase 3 trials in refractory status epilepticus and tuberous sclerosis complex." Under the terms of the revenue interest financing agreement, Sagard will provide Marinus with an upfront cash payment of $32.5M in exchange for tiered payments on annual U.S. net sales of ganaxolone, including ZTALMY, as follows: 7.5% on net sales through the first half of 2026; after that, 15% on net sales less than $100 million annually; and 7.5% on net sales greater than $100 million annually, providing an average rate of approximately 10% based on current sales forecasts. The total amount payable by Marinus to Sagard is capped at 1.9x of the upfront payment, with the ability to redeem the revenue interest financing agreement at lower multiples within the first four years from funding. Upon achievement of the cap amount, the revenue interest financing agreement will terminate. "Sagard is excited to complete this transaction with Marinus and help support the ongoing launch of ZTALMY and the development of ganaxolone," said Raja Manchanda, Partner at Sagard. "Sagard's investment reflects our confidence in Marinus' commercial opportunity and their mission to help provide patients with access to an important and novel therapy for the treatment of seizure disorders."

07:24 EDT ParkerVision appoints Sanford Litvack to board of directors - ParkerVision announced that it has named Sanford Litvack to its Board of Directors, expanding the Board to five members, four of whom are independent. Litvack is a partner with Chaffetz Lindsey LLP and has a broad corporate litigation background, handling a wide array of complex matters, including patent and other intellectual property issues.

07:21 EDT Ainos pursues licensing partners for five drug candidates for VELDONA - Ainos announced that it is pursuing out-licensing opportunities for five new drug candidates for its low-dose oral interferon-alpha formulation, VELDONA. Ainos has completed Phase 2 trials for the five new drug candidates and will work with potential partners to accelerate the candidates to Phase 3 trials and eventual commercialization of VELDONA. The following five indications have completed Phase 2 trials. Ainos aims to enter out-licensing agreements to advance VELDONA to Phase 3 trials and commercialization. Sjogren's syndrome; Aphthous Stomatitis; Chemotherapy-induced Stomatitis; Influenza; Common Cold. The Company's product is delivered into the oral cavity as a lozenge in low doses. Human studies have shown that IFNalpha given orally is effective against viral and autoimmune diseases, without the side effects associated with high-dose injections of IFNalpha. Ainos has cumulatively spent nearly $40 million on developments related to the oral use of IFNalpha not including the expected expenses on clinical trials and manufacturing VELDONA. To date, 68 clinical trials have been conducted with low-dose oral IFNalpha. Sixty-three studies were Phase 2 trials, and three Phase 1 and two Phase 3 studies have also been conducted. Nearly 6,000 patients with one of 16 different disease indications and/or healthy volunteers participated in these trials, including a total of 4,600 subjects exposed to IFNalpha at a dose level ranging from three to 2,000 international units given daily for up to five years. The safety of orally administered IFNalpha has been consistently demonstrated in these trials. Interferons are proteins made by host cells in response to the presence of pathogens such as viruses, bacteria, parasites, or tumor cells. They allow for communication between cells to trigger the protective defenses of the immune system that eradicate pathogens or tumors. Of the nine different families of human interferon that have been identified, interferon-alpha is the most widely studied. The US FDA has approved the use of IFNalpha in mega doses given by injection for treating a number of cancers, as well as Hepatitis B and C. Ainos's low-dose oral VELDONA formulation is designed to enhance autoimmunity to resist virus damage, potentially reducing side effects and risks caused by high-dose interferon and other small molecule drugs.

07:19 EDT Diversified Energy closes securitized financing - Diversified Energy Company is pleased to announce that on 27 October 2022 Diversified and Oaktree Capital Management, L.P. jointly closed an ESG-aligned asset backed securitization of certain co-owned producing natural gas and oil assets located in Oklahoma. This fourth ESG-aligned financing in 2022 is linked to key performance indicators based on emissions reduction targets. Diversified had previously pledged its portion of the Assets as collateral under the Company's Sustainability-Linked Loan. Diversified will use its ABS proceeds to repay all outstanding borrowings under its SLL and for general corporate purposes, resulting in current liquidity of approximately $300 million, inclusive of the financing of the ConocoPhillips acquisition announced on 28 July 2022.

07:17 EDT Microbot Medical appoints Baere to its scientific advisory board - Microbot Medical announced that Thierry Jacques De Baere, MD, PhD, is joining the Company's Scientific Advisory Board, SAB. Dr. De Baere is head of the Interventional Radiology Unit at Institut Gustave Roussy Cancer Center in Villejuif, France, the largest cancer center in Europe.

07:16 EDT WiSA Technologies moves forward with exploration of strategic alternatives - WiSA Technologies is moving forward in its exploration of strategic alternatives to consider a wide range of options for the company. To explore strategic opportunities specifically involving the company's IP and licensable software used in WiSA E and WiSA DS technologies, the board of directors approved the engagement of AQ Technology Partners during the third quarter to assist in this process. To date, four companies have executed NDAs in consideration of a potential transaction. The company, with its advisors, is evaluating a broad range of strategic transactions. Potential strategic transactions that may be explored or evaluated as part of this process include the potential for capital raising transactions, an acquisition, sale of assets, including substantially all of the company's assets, merger, business combination, partnership, joint venture, licensing and/or another strategic alternative. Despite devoting efforts to identify and evaluate potential strategic transactions, the process may not result in any definitive offer to consummate a strategic transaction, or, if WiSA Technologies receives such a definitive offer, the terms may not be as favorable as anticipated or may not result in the execution or approval of a definitive agreement. Even if the company enters into a definitive agreement, the company may not be successful in completing a transaction or, if it completes such a transaction, it may not enhance stockholder value or deliver expected benefits. WiSA Technologies, Inc. does not expect to disclose developments with respect to this process unless or until the evaluation of strategic alternatives has been completed or the Board of Directors has concluded disclosure is appropriate or legally required.

07:13 EDT AxoGen appoints Tyndall to board, founding director Gold to retire - Axogen announced that effective December 13, 2022, Adrian Tyndall, M.D., MPH, FACEP has been appointed as an independent member to the company's board of directors and will serve on the Quality, Compliance, and Portfolio Management Committee. The company also announced that Mark Gold, M.D. a founding director, will retire from the board of directors on the Effective Date. Dr. Gold will continue to serve the Board of Directors until that time. Joseph "Adrian" Tyndall, MD, MPH, FACEP is currently the Executive Vice President for Health Affairs and Dean of Morehouse School of Medicine.

07:11 EDT ADMA Biologics receives FDA approval for seventh plasma collection center - ADMA Biologic announced that it has received U.S. Food and Drug Administration, FDA, approval for its seventh ADMA BioCenters plasma collection facility located in Greensboro, North Carolina. This plasma collection facility commenced operations and initiated source plasma collection in the first quarter of 2022. With the approval announced today, this facility is now FDA-approved to collect and introduce into interstate commerce, human source plasma for further manufacturing in the U.S. "The successful expansion of ADMA's plasma collection network supports the Company's goal of plasma supply self-sufficiency, ongoing revenue growth objectives, and further supports the pathway towards profitability. The approval is a testament to the BioCenters team's tireless commitment, and we thank the FDA for its efforts and expeditious review of the Greensboro, NC Biologics License Application, which came in advance of ADMA's anticipated approval date," said Adam Grossman, President and Chief Executive Officer of ADMA.

07:10 EDT Verve Therapeutics announces publication of VERVE-101 preclinical data - Verve Therapeutics announced that preclinical data supporting VERVE-101 as a treatment for heterozygous familial hypercholesterolemia, HeFH, a genetic form of atherosclerotic cardiovascular disease, ASCVD, has been published in the American Heart Association's peer-reviewed journal Circulation. The published findings are from a study in non-human primates, in which animals received a one-time infusion of a control or VERVE-101 at a dose of 0.75 mg/kg or 1.5 mg/kg. The animals in the 0.75 mg/kg arm were evaluated 365 days post-treatment and demonstrated a mean reduction in blood PCSK9 protein of 67% and LDL-C reduction of 49% from baseline. The animals that received the 1.5 mg/kg dose were evaluated at up to 476 days post-treatment and demonstrated a mean reduction in PCSK9 protein of 83% and LDL-C reduction of 69% from baseline. Liver safety measurements assessed one year after dosing were normal in all treated animals and liver microscopic examinations in a subset of NHPs who underwent scheduled necropsy were normal. In addition, a second set of experiments evaluated the potential for VERVE-101 to edit germline cells or be passed on to offspring. In six sexually mature male NHPs, sequencing of sperm samples before and after treatment with VERVE-101 showed no evidence of PCSK9 gene editing. Genotyping of 436 offspring of female mice treated with the murine surrogate of VERVE-101 observed that the PCSK9 edit was not transmitted to any of the offspring. "The totality of data generated for our VERVE-101 program support our ongoing heart-1 global clinical program and the potential of VERVE-101 as a single-course treatment for HeFH," said Andrew Bellinger, M.D., Ph.D., chief medical and scientific officer of Verve. "The consistency of preclinical data showing durable editing of the PCSK9 gene and lowering of LDL-C, combined with these new findings showing no evidence of germline transmission, bolster our confidence in the potential for VERVE-101 to offer a long-term, well-tolerated treatment for patients with HeFH and for patients with established ASCVD not at LDL-C goal on oral therapy."

07:08 EDT Agrify regains compliance with Nasdaq's listing requirements - Agrify announced that it has received written notice from The Nasdaq Stock Market informing the Company that it has regained compliance with Nasdaq's minimum bid price listing requirement. The Company has satisfied the terms for continued listing on the Nasdaq Capital Market by complying with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). Accordingly, Nasdaq has advised that the matter is now closed. The Company believes the completion of its reverse stock split and subsequent reattainment of compliance with Nasdaq's listing requirements enables the Company to potentially achieve several important corporate objectives, including but not limited to, the ability to augment Agrify's visibility within the investment community, broaden its shareholder base, and meet certain security eligibility criteria for consideration for inclusion into market-wide and cannabis sector indices.

07:07 EDT Excel Energy leases Anterix spectrum in eight states - Xcel Energy (XEL) subsidiary Xcel Energy Services has signed an agreement providing Xcel Energy the use of Anterix's (ATEX) 900 MHz spectrum throughout the company's service territory in eight western and midwestern states. The agreement provides Xcel Energy dedicated use of the 900 MHz spectrum for 20 years, with two optional ten-year extensions. Xcel Energy plans to use the spectrum to deploy a private LTE network to support its grid modernization initiatives for the benefit of its 3.7 million electricity customers and 2.1 million natural gas customers. Xcel Energy has conducted an extensive investigation of LTE technology and Anterix's 900 MHz spectrum. Beginning in 2019, Xcel Energy joined with Anterix, six other utilities, and the National Renewable Energy Laboratory in a "high impact" project that validated the performance of 900 MHz LTE in utility use cases. As part of the agreement, Xcel Energy has also committed to an ongoing collaboration with Anterix which includes joining the Utility Strategic Advisory Board of the Anterix platform. In addition, Xcel Energy will support technology trials with Anterix spectrum solutions and management services and will also contribute to the Anterix Active Ecosystem on key initiatives that support and address the current and future needs of utilities.

07:05 EDT GreenPower Motor launches second round of pilot project with West Virginia - GreenPower Motor announced the launch of the second round of its pilot project with the state of West Virginia to demonstrate all-electric school buses in Clay, Grant, Monongalia and Ohio county school districts. The second round of the pilot program will incorporate new terrains, colder weather and longer school bus routes. Three all-electric GreenPower Type D BEAST school buses will be deployed in Grant, Monongalia and Ohio school districts, while Clay County will deploy the first all-electric Type A Nano BEAST with ADA capabilities in the state of West Virginia. As in the first round, GreenPower will work with the school districts to ensure adequate charging infrastructure is provided for the pilot. This is the second round of GreenPower's pilot project done in cooperation with Gov. Jim Justice, the West Virginia Department of Economic Development and the West Virginia Department of Education.

07:05 EDT zTrip to go public via business combination with Spree Acquisition Corp. 1 - WHC Worldwide, LLC, doing business as zTrip and Spree Acquisition Corp. 1 Limited announced they have entered into a business combination agreement that would result in zTrip becoming publicly listed on the NYSE. Upon closing of the transaction, the combined company will be named WHC Worldwide, Inc. and is expected to be listed on the NYSE under the ticker "ZTRP." The combined company will be led by zTrip's founder and CEO, Mr. Bill George. zTrip was formed in January 2018 to develop a platform capable of operating local mobility service providers more effectively and efficiently. Since that time, its focus has been on building a national network of taxi operators and transportation service providers. Combining its experience of acquiring and operating traditional taxi fleets having completed 28 acquisitions of local operators to date, on a path towards establishing national scale with its proprietary technology-based shared infrastructure, zTrip aims to consolidate the local mobility service market and drive greater technology adoption and other operating efficiencies. zTrip is the largest taxi fleet operator in the U.S., operating in 26 cities with more than 2,700 vehicles and over 3,170 contracted drivers on its platform. zTrip provides mobility services to approximately 1,080 corporate clients, providing a significant continuing revenue base, including in the following sub-sectors: student transportation; jobs training transfers; employment shuttles; airport transportation; conventions shuttles; large hospital networks; microtransit; local transportation authorities; and national Non-Emergency Medical Transportation brokers. zTrip's assumed equity value prior to the business combination is $251 million. Spree is required to provide gross proceeds of at least $50 million to zTrip. The combined company that will result from the transaction will be organized in an "Up-C" tax structure; WHC Worldwide, Inc., a Delaware corporation to be formed based on the transfer and domestication of Spree, will be a publicly listed holding company, which will hold equity interests in WHC Worldwide and its subsidiaries, which, in turn, will hold and operate substantially all of the assets and business of zTrip. The closing of the transaction is expected to occur during the first half of 2023. The business combination agreement provides that zTrip's assumed equity value prior to the business combination is $251 million, subject to certain adjustments prior to closing. Subject to the approval by Spree's shareholders of the business combination and after giving effect to any redemptions of Class A ordinary shares by Spree's public shareholders, Spree will migrate from the Cayman Islands to Delaware and domesticate as a Delaware corporation, with its name to be changed to "WHC Worldwide, Inc." At the effective time of the domestication, each outstanding Class A ordinary share and Class B ordinary share, and each warrant, of Spree will convert on a one-for-one basis into shares of Class A common stock, and warrants, respectively, of WHC Worldwide, Inc. At the closing, WHC Worldwide, Inc. will contribute to WHC Worldwide, LLC the amount of remaining cash from Spree's IPO in Spree's trust account after giving effect to the exercise of redemption rights by any Spree shareholders, plus the aggregate cash proceeds to be received from a PIPE investment in the combined company. In exchange for that contribution, WHC Worldwide, LLC will issue to WHC Worldwide, Inc. a certain number of WHC Worldwide, LLC Class A common units and WHC Worldwide, Inc. will issue to WHC Worldwide, LLC, and WHC Worldwide, LLC will in turn distribute to its preexisting members, a number of shares of Class X common stock of WHC Worldwide, equal to the number of WHC Worldwide, LLC units held by each such member. Following the transaction, those shares of WHC Worldwide, Inc. Class X common stock, together with the WHC Worldwide, LLC units, to be held by WHC Worldwide, LLC's preexisting members, may be forfeited and redeemed for shares of WHC Worldwide, Inc. Class A common stock or, at WHC Worldwide, LLC's option, cash. The business combination, which has been unanimously approved by the board of directors of Spree and the managers and members of WHC, is expected to close in the first half of 2023. Closing is subject to the satisfaction of specific conditions, including Spree having on its balance sheet at the closing cash in a minimal amount of at least $50 million. Closing is also subject to certain additional, customary closing conditions, such as the approval of the transaction by Spree's shareholders and the NYSE's approval of the initial listing application for the WHC Worldwide, Inc. Class A common stock to be issued to Spree's existing shareholders in connection with the business combination.

07:04 EDT Essa Pharma: Janssen suspends enrollment in Phase 1 study of EPI-7386 - ESSA Pharma announced that Janssen Research and Development is suspending enrollment into the Phase 1 clinical study of EPI-7386 with apalutamide or EPI-7386 with abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer patients as a result of operational recruitment challenges. Before suspending enrollment, Janssen treated three mCRPC patients with the combination of EPI-7386 and apalutamide or abiraterone acetate plus prednisone for up to four months of therapy. In all three patients, the combination of both investigational drug products was safe and well tolerated, and yielded sufficient exposures of each investigational drug product, indicative of pharmacological activity. Initial clinical activity was observed in some patients, with two of the three patients achieving a prostate-specific antigen reduction of 90% within 12 weeks. "While we are disappointed that Janssen will not be completing this study, we thank Janssen for the conduct of the study to date and the patients who participated in the study. We are encouraged by the favorable safety, pharmacokinetic, and initial clinical activity in these patients as these data further support the data generated in the EPI-7386 combination study with enzalutamide that ESSA is conducting. We are in discussions with Janssen to supply abiraterone acetate and apalutamide for an ESSA-sponsored combination study and expect to provide more details in the coming months," said David Parkinson, CEO of ESSA.

07:01 EDT Northern Dynasty comments on Transportation and Infrastructure Committee report - Northern Dynasty reported that John Shively, CEO of its 100%-owned U.S.-based subsidiary Pebble Limited Partnership released the following statement about last Friday's Transportation and Infrastructure Committee report on the Pebble mine. The statement, reiterated in full below, read: "To begin, we have not had time to fully review the 163 page report. It was clearly shared with some of the media before it was shared with us. Thus, our comments are initial and we will have more to share with the public. We want to be absolutely clear, however, that to the extent the report contains any suggestion that we tried to mislead regulators in any way, it is categorically wrong and misinformed of the realities of the Pebble permitting process. We have been forthright and clear in all of our public communications and with regulators that Pebble would need to be permitted in phases. We have been equally clear with all stakeholders that: (a) we were planning to construct and operate an initial mine at Pebble for twenty years, (b) that initial plan did not mine the entire resource, and (c) at some future time, we would likely consider an expansion, but had no formal specific plans for additional mining at Pebble (nor could we given the contingencies associated with the initial phase submitted for permitting). This information was also presented in the Environmental Impact Statement ("EIS") process and related documents for the project. A quick search on the term "expansion scenario" which was what they used for the large mine in the EIS yields more than 300 hits scattered throughout the EIS. We have been up front that the resource and opportunity at Pebble are significant and that any future opportunity would require another comprehensive permitting process. We openly shared all of this with the committee and are extremely disappointed with the politicization of the so-called review of the project that is inconsistent with reality. We look forward to laying out the essential context missing from the report."

06:54 EDT SunCoke Energy sees FY22 domestic coke production 4.1M tons - Sees FY22 adjusted EBITDA $285M. Sees FY22 capital expenditures $80M. Sees FY22 cash generated by operations $200M-$215M.

06:50 EDT Albemarle general counsel Karen Narwold to retire, Kristin Coleman to succeed - Albemarle announced that Karen Narwold, executive vice president, chief administrative officer, general counsel, and corporate secretary, will retire from Albemarle effective April 4, 2023. Kristin Coleman will join the company as executive vice president, general counsel, and corporate secretary on November 28, 2023. Coleman will report to J. Kent Masters, chairman and CEO.

06:46 EDT KalVista's sebetralstata shows positive Phase 1 data in angioedema - KalVista Pharmaceuticals announced positive phase 1 data for an orally disintegrating tablet formulation for its lead compound sebetralstat. Sebetralstat is currently being developed in the phase 3 KONFIDENT clinical trial as a potential on-demand treatment for hereditary angioedema - HAE - attacks. KalVista recently completed a clinical trial to investigate the pharmacokinetics of the ODT. The phase 1, open-label, randomized, single-dose, 3-way crossover trial enrolled 36 healthy adult volunteers to compare the pharmacokinetics of sebetralstat following administration of ODT and the current film-coated tablets in healthy adult volunteers. Data from the study showed that the ODT tablet formulation has a similar PK profile to the film-coated version currently in development. Based upon these results, KalVista intends to continue to develop the formulation with the intention to make it available as soon as possible after the sebetralstat anticipated launch in the US. KalVista currently expects that data from the KONFIDENT study using the film-coated tablets will be available in the second half of 2023, to support a planned NDA filing in the first half of 2024.

06:32 EDT Quotient to effect one-for-40 reverse stock split - Quotient will effect a one-for-40 reverse stock split of its ordinary shares, nil par value that will become effective on November 2 at 5:01 p.m. Eastern Time, after the close of trading on Nasdaq. The company's Ordinary Shares are expected to begin trading on a split-adjusted basis when the market opens on November 3, 2022 on the Nasdaq under the existing symbol "QTNT." The reverse stock split is primarily intended to bring the Company into compliance with the minimum bid price requirement for maintaining its listing on Nasdaq. The new CUSIP number for the Ordinary Shares following the Reverse Stock Split will be G73268149. The Reverse Stock Split will affect all issued and outstanding Ordinary Shares. No fractional shares will be issued in connection with the Reverse Stock Split. The Reverse Stock Split will reduce the number of shares of Ordinary Shares issued and outstanding from approximately 141'208'378 to approximately 3'530'209.

06:14 EDT Loews CEO Jonathan Tisch to switch to chairman role, Alex Tisch to succeed - Loews announced that CEO Jonathan Tisch will assume the role of executive chairman and Alex Tisch will become president and CEO, effective January 1, 2023. Jon Tisch will remain co-chairman of the board of Loews, serving along with Andrew Tisch. As an officer of Loews Hotels since 1986, Jon Tisch engineered the company's expansion and emergence as an industry leader. His longstanding focus on strategic partnerships and creation of a unique corporate culture has resulted in strong profitability. Loews Hotels' culture is widely praised for empowering its team members, satisfying its customers and contributing to its communities. Tisch serves as the chairman emeritus of the United States Travel Association, the successor organization to the Travel Business Roundtable, which he founded.

06:11 EDT AstraZeneca to present over 60 abstracts at ASN and AHA events this week - The company states: "AstraZeneca will present over 60 abstracts across its industry-leading Cardiovascular, Renal and Metabolism portfolio and from Alexion, AstraZeneca's Rare Disease group, at the American Society of Nephrology, ASN, Kidney Week from 3-6 November 2022 and the American Heart Association, AHA, Scientific Sessions occurring 5-7 November 2022. With robust science across both medical congresses, AstraZeneca demonstrates its ambition to fundamentally transform cardiorenal care and advance patient outcomes by unravelling the underlying causes of disease, developing diagnostic strategies and delivering innovative, life-changing solutions for the millions of people affected by this interconnected spectrum of diseases. Additionally, Alexion will present data highlighting scientific advancements that further the understanding of complement inhibition in the treatment of rare nephrology diseases." Reference Link

06:03 EDT Tutor Perini unit awarded two contracts valued at $90M - Tutor Perini announced that its subsidiary, Five Star Electric, has been awarded two new contracts collectively valued at approximately $90M. Five Star, in a joint venture with Yonkers Contracting, was awarded a design-build contract by the Port Authority of New York and New Jersey for a new two-story substation building at JFK International Airport, which will provide power to the new JFK Terminal 1. The project scope of work for Five Star includes furnishing and installing 27kV switchgear, 15kV switchgear, medium-voltage cables, low-voltage power distribution equipment, security, lighting, fire alarm and other electrical systems. Work recently commenced and substantial completion is anticipated in the spring of 2024. The contract value will be included in the company's third-quarter 2022 backlog. Five Star, working as a subcontractor to Yonkers Contracting, was awarded the electrical component of a project to construct a new two-story substation building in Jersey City, NJ. Five Star's scope of work entails furnishing and installing all electrical systems, including switchgear, supervisory control and data acquisition systems, traction power transformers, medium-voltage and traction power cables, low-voltage power distribution equipment, security, lighting and testing, as well as all raceways and feeders. In addition, traction power feeders will be installed from the new substation building to the existing PATH tunnels. Work will commence in the fourth quarter of 2022 and substantial completion is anticipated in the summer of 2026. The contract value will be included in the company's fourth-quarter 2022 backlog.

05:51 EDT TuSimple terminates CEO, chairman Xiaodi Hou - TuSimple announced that the board of directors of the company has terminated Xiaodi Hou, the CEO, president and CTO of the company, and removed Hou from his position as chairman of the board and as a member of the Government Security Committee, effective as of October 30. The company announced that Ersin Yumer, TuSimple's executive VP of operations, has agreed to serve as interim CEO and president of the company during the pendency of the executive search. Brad Buss, lead independent director, will be chairman of the board. The board is also actively engaged in the search to add new independent members to the board. These actions have been taken in connection with an ongoing investigation led by the Audit Committee of the board that led the board to conclude that a change of CEO was necessary.

05:19 EDT Stellantis, GAC-FCA shareholders approve bankruptcy resolution - The shareholders of the GAC-FCA Joint Venture, Guangzhou Automobile Group Co and Stellantis N.V., have approved a resolution authorizing the joint venture to file for bankruptcy, in a loss-making context. Stellantis fully impaired the value of its investment in the GAC-FCA JV and other related assets in its first half 2022 financial results. Stellantis will continue providing quality services to existing and future Jeep brand customers in China.

05:10 EDT Full Truck Alliance announces 33.5M fulfilled orders with GTV of RMB 69.6B in Q3 - Full Truck Alliance announced that the company facilitated 33.5M fulfilled orders with Gross Transaction Value, or GTV, of RMB 69.6B in the third quarter ended September 30, representing 5.4% year-over-year decrease and 3.5% year-over-year increase, respectively.